The protein kinase Akt mediates several metabolic and mitogenic effects of insulin, whereas activation of protein kinase C (PKC) isoforms has been implicated in the inhibition of insulin action. We have previously shown that both PKCθ and PKCε are activated in skeletal muscle of insulin resistant high fat-fed rats, and in order to identify potential substrates for these kinases, we incubated recombinant PKC isoforms with rat muscle fractions in vitro. PKCθ specifically phosphorylated a 48 kDa protein which was subsequently identified by mass spectrometry as Ndrg2. Ndrg2 is highly related to N-myc downstream-regulated protein 1, which has been linked to stress responses, cell proliferation and differentiation, although Ndrg2 itself is not repressed by N-myc. Ndrg2 contains several potential phosphorylation sites including three Akt consensus sequences. Ndrg2 phosphorylation was enhanced in [ 32 P]orthophosphate-labelled C2C12 muscle cells co-overexpressing either PKCθ or Akt. Phosphorylation of Ndrg2 was examined further using a phospho (Ser/Thr) Akt substrate antibody. Insulin increased Ndrg2 phosphorylation in C2C12 cells in a wortmannin-and palmitate-inhibitable manner, while rapamycin, PD98059 and bisindoylmaleimide I had no effect, supporting a direct role for Akt. Mutation of Ndrg2 indicated that Thr348 is the major phosphorylation site detected by the antibody, and that Akt stimulates phosphorylation of this site whereas as PKCθ phosphorylates Ser332. We did not detect any effects of insulin on protein binding or the cellular location of Ndrg2. PKCθ overexpression, however, diminished the effect of insulin on Thr348 phosphorylation without reducing Akt activation, suggesting that this is mediated through phosphorylation of Ndrg2 at Ser332. Our data identify Ndrg2 as a novel insulin-dependent phosphoprotein and suggest that PKCθ may inhibit insulin action in part by reducing its phosphorylation by Akt.
INTRODUCTION
The acute activation of the lipid-dependent Ser/Thr protein kinase PKC 1 has been wellcharacterised. Three groups of PKC have been established: the cPKCs α, β and γ which are activated by calcium and DAG; the nPKCs, e.g. δ, ε and θ, which require DAG and the aPKCs ζ and ι/λ which are independent of both calcium and DAG (1) . The essential role of specific binding partners such as the RACKS and A-Kinase anchoring proteins in the spatial coordination of PKC isoforms is also becoming apparent (2) . Similarly, a number of substrates which are directly phosphorylated by PKCs in particular cell types, and which mediate PKC effects on cellular regulation, are emerging.
Specific PKC isoforms have been implicated in the inhibition of insulin action. Insulin resistance of target tissues such as skeletal muscle is a major contributing factor to the development of type 2 diabetes, and activation of nPKCs, including PKCθ, have been correlated with insulin resistance in a number of studies, especially in association with increased lipid availability (3, 4) .
The mechanisms involved, however, including the targets for PKC-mediated phosphorylation, remain unclear. PKCs could interfere at one or more steps in insulin signal transduction, and the possibility that they may mediate increased Ser/Thr phosphorylation of IRS-1 is currently insulin stimulation, and this was inhibited in the presence of PKCθ activity. Our data therefore indicate that Ndrg2 is a novel target for Akt, and may represent a site for PKC-mediated inhibition of insulin signal transduction.
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Preparation of crude muscle fractions-Solubilized membrane fractions were prepared from red quadriceps muscle of male wistar rats. Muscles (5 g) were homogenised in 20 ml of ice-cold buffer A (20mM MOPS, pH 7.5, 4 % (v/v) glycerol, 250 mM mannitol, 1 mM EGTA, 1 mM EDTA, 1 mM DTT, 2 mM PMSF, 200 µg/ml leupeptin, 2 mM benzamidine) and centrifuged at 100,000 g for 45 minutes. This and all subsequent purification procedures were carried out at 4°C. The supernatant was retained as the cytosolic fraction. The pellet was washed by resuspension with Buffer A and recentrifuged. The washed pellet was resuspended with 20 ml Buffer B (20mM MOPS, pH 7.5, 4 %( v/v) glycerol, 1 mM EGTA, 1 mM EDTA, 0.5% (w/v) decanoyl-N-methyl-glucamide, 1 mM DTT, 2 mM PMSF, 200 µg/ml leupeptin, 2 mM benzamidine). After incubation at 4°C for 1 h, the suspension was again centrifuged and the supernatant retained as the crude membrane fraction.
Further fractionation of muscle proteins-The crude membrane fraction was applied to a 1 ml Mono Q column equilibrated in buffer B, and proteins eluted with a 0.05 -1 M NaCl gradient in buffer B to yield 30 fractions over 30 ml. Alternatively, the membrane fraction was applied to a 1ml hydroxyapatite column equilibrated with Buffer B containing 20 mM KH 2 PO 4 . Proteins were eluted with a 20 -300 mM KH 2 PO 4 gradient in Buffer B to yield 30 fractions over 30 ml.
8 of these PKC isoforms in insect Sf9 cells using the PharMingen BaculoGold System according to the manufacturer's instructions. Sf9 cells from three 150 cm 2 culture flasks, which had been infected 3 days previously with baculoviruses for the overexpression of either PKCθ or PKCε, were harvested and washed in PBS prior to sonication (15 pulses, using a Branson 250 Sonifier and microtip at 20% duty cycle, power setting 2) in 5 ml Buffer C (20 mM MOPS, pH 7.5, 150
mM NaCl, 4 % (v/v) glycerol, 1% (v/v) Tween 80, 2 mM PMSF, 200 µg/ml leupeptin, 2 mM benzamidine). Extracts were centrifuged at 100,000 g for 40 min and supernatants applied at 0.1 ml/min to a 1 ml Ni-NTA Superflow equilibrated with Buffer C. The column was washed firstly with 10 ml Buffer C then with 10 ml Buffer C containing 50 mM imidazole. Finally, 6-Histagged PKCs were eluted in 0.5 ml fractions with Buffer C containing 250 mM imidazole. Peak PKC-containing fractions, identified by SDS-PAGE and coomassie staining, were diluted with glycerol (final concentration 50% (v/v)) and stored at -20°C.
In vitro phosphorylation of muscle proteins-Crude membrane and chromatography fractions (10µl) were incubated at 30°C in the absence or presence of purified recombinant 6-His-tagged PKCε or PKCθ, in a final volume of 50µl, containing in addition 20mM MOPS, 0.04% (v/v) Triton X-100, 1 mM EGTA, 120 nM cAMP-dependent protein kinase inhibitor peptide, 120 µg/ml α-phosphatidyl-L-serine, 2.5 µg/ml 1,2-dioctanoyl-sn-glycerol and 100 µM [γ- Large-scale purification of pp48-Rat red quadriceps muscle (50 g) was homogenised in 200 ml buffer A and a solubilized membrane fraction prepared as above. This was applied to a 25 ml High Q column equilibrated with buffer B containing 50 mM NaCl, and protein eluted with a non-linear gradient of 50 -500 mM NaCl over 40 fractions of 12.5 ml, followed by 500 -1000 mM over 10 fractions of 12.5 ml. Fractions were subjected to phosphorylation by PKCθ and those containing pp48 (fractions [13] [14] [15] [16] [17] were pooled and applied to a 25 ml ceramic hydroxyapatite column equilibrated in buffer B containing 2 mM KH 2 PO 4 , which was further washed with 125 ml of 2 mM KH 2 PO 4 . Proteins were eluted with a non-linear gradient of 2 -75 mM KH 2 PO 4 in buffer B over 25 fractions of 12.5 ml followed by 75-150 mM over 10 fractions of 12.5 ml. pp48 was found by in vitro phosphorylation by PKCθ to be present mainly in the initial flow-through of this purification step, and this fraction (60 ml) was concentrated to 1.0 ml under vacuum using a Filtron Omegacell 10 ml stirred cell device with 30 kDa molecular weight cut-off membrane.
2-DE of pp48-200µl concentrated pp48 was phosphorylated by incubation with PKCθ as detailed above, in a final volume of 1 ml. The reaction mixture was dialysed against 2 changes of deionised water using a Slide-A-Lyzer cassette with 10 kDa cut-off membrane, and freeze-dried.
For first dimension IEF, the sample was rehydrated with 250 µl 8M urea, 0.5% IPG buffer (pH 4 -7), 2% (w/v) CHAPS, and 100 mM DTT and the solution used to rehydrate a 13 cm pH 4 -7 IPG strip for 16 h. Proteins were focussed on the IPG strip using a Pharmacia IPGphor isoelectric focusing unit at 500 V for 1 h, followed by 1000 V for 1 h and finally 8000 V for 2 h.
The IPG strip was then equilibrated in 50 mM Tris-HCl, pH 8.8, 6M urea, 30 % (v/v) glycerol, 2 % (w/v) SDS and a trace amount of bromophenol blue, and subjected to SDS-PAGE in the second dimension, using a 14 x 15 x 0.15 cm 10 % (w/v) polyacrylamide gel. The gel was silverstained (18) and subjected to phosphorimaging.
Protein Identification by Mass Spectrometry-32 P-labelled protein spots were excised from silver-stained gels, vacuum-dried, and subjected to tryptic digestion as adapted from Shevchenko et al. (18 (19) . A quaternary Hewlett-Packard 1100 series HPLC was directly coupled to a Finnigan MAT TSQ7000 mass spectrometer equipped with an in-house built microspray device for peptide ionisation. MS/MS spectra were correlated with database entries using SEQUEST (Thermo Finnigan, Sydney, Australia), a program which correlates uninterpreted peptide fragmentation patterns with amino acid sequences contained in databases, and is also capable of identifying phosphorylation sites from uninterpreted MS/MS spectra (20).
Ndrg2 phosphorylation site mutants-Ser332Ala, Thr348Ala and Ser350Ala Ndrg2 mutants were generated by PCR-based mutagenesis of wild type mouse Ndrg2 cDNA in the pCMV/SVFlag1 vector using 5'-CGGTCTCGCACAGCAGCTCTGACCAGTGCAGCA-3', 5'-
primers respectively. The Ser332Ala/Thr348Ala/Ser350Ala combined mutant was generated by PCR-based mutagenesis of the Ser332Ala Ndrg2 construct using 5'-GGGCCCATCGATGGCAGTCGGTCCCGATCCCGCGCCCTGGCGCAGAGTAGCG -3' as a primer. All mutations were confirmed by DNA sequence analysis.
Mouse C2C12 skeletal muscle cell culture and transfection-Cells were maintained as myoblasts in EMEM supplemented with 10 % (v/v) FBS, and where stated induced to differentiate into myotubes by lowering FBS concentration to 1 % (v/v), as previously described (21 Palmitate pretreatment of cells was as described previously (21) .
Adenovirus-mediated overexpression of proteins in C2C12 myotubes-The use of recombinant adenoviruses for the overexpression of constitutively active Akt, wild type PKCθ or wild type PKCε, together with GFP in C2C12 myotubes, generated using the pAdEasy system (22), has been previously described (23, 24) . The pAdEasy system was also used to generate adenoviruses for the expression of Ndrg2 constructs, enabling co-expression of GFP and Ndrg2. A pAdEasyderived virus expressing GFP alone was used in control infections. Immunoblotting, densitometry and statistical analysis were carried out as described previously (3) . Primary antibodies were diluted 1:1000 except for anti-PKCθ (1:250).
2-dimensional tryptic phosphopeptide mapping-Ndrg2 immunoprecipitated from Triton X-100 in PBS, and blocked with 2% (w/v) BSA in PBS. Cells were subsequently stained with both rabbit polyclonal anti-FLAG and FITC-conjugated anti-actin antibodies for 2 h. After
RESULTS

Identification of Ndrg2 as a PKCθ-specific substrate in skeletal muscle
The nPKC isoforms PKCθ and PKCε have been strongly implicated in the generation of lipidinduced insulin resistance in skeletal muscle, although the precise mechanisms involved are
unclear. An indication of potential substrates for nPKCs in skeletal muscle was obtained by employing purified recombinant PKC isoforms to phosphorylate muscle proteins in vitro. PKCθ was able to phosphorylate a 48 kDa protein (pp48) in crude preparations, which was best observed in membrane fractions ( were observed in phosphorimages, demonstrating that pp48 was not co-purified with PKCθ from Sf9 insect cells (Fig. 1D ).
In order to identify pp48, the protein was partly-purified by sequential MonoQ and hydroxyapatite chromatography and again phosphorylated by incubation with PKCθ, prior to 2-DE, followed by silver staining and phosphorimaging ( Fig. 2A) . The major spot observed in the phosphorimage coincided with a major 48 kDa silver-stained protein spot, which was excised from the gel and subjected to tryptic digestion. PKCθ (pI = 8.2) focuses outside the pH range employed and so is not observed here. Tryptic peptides from pp48 were analysed by µLC/ESI-MS/MS, and three peptides corresponding to the amino acid sequence of rat Ndrg2 (14) were identified ( Fig. 2B ). The presence of the peptide corresponding to residues 26-32 ( Fig. 2B & C) indicated that the Ndrg2a 1 /Ndrg2b 1 isoform (Swiss-Prot/TrEMBL accession number Q8VBU2) must be present (14) . This protein has also been termed Antidepressant-related protein ADRG123 (Q8VI01).
Phosphorylation of Ndrg2 in intact mouse C2C12 skeletal muscle cells
Interestingly, the tryptic peptide corresponding to amino acids 330-343 was found to be phosphorylated at Ser332 (Fig. 2B ). The C-terminus of Ndrg2 is enriched in Arg and Ser residues, and thus contains a number of potential phosphorylation sites not only for PKC but other basophilic kinases (Fig. 2C) . Analysis of the region from Ser328 using the program Scansite 2.0 (28) reveals 8 potential sites for combinations of 8 different kinases at low stringency. Unfortunately, a consensus sequence for PKCθ has not been defined. To determine whether PKCθ could specifically phosphorylate Ndrg2 in intact cells, we overexpressed PKCθ and PKCε with FLAG-tagged mouse Ndrg2, which is highly homologous to rat Ndrg2 ( Fig. 2C ), in C2C12 mouse skeletal muscle cells. Cells were co-transfected with PKC isoforms followed by metabolic labelling with [ 32 P]orthophosphate. Ndrg2 was immunoprecipitated and subjected to either phosphorimaging or immunoblotting with FLAG antibody (Fig. 3A) . In agreement with our in vitro experiments, PKCθ overexpression caused increased phosphorylation of Ndrg2 (3.9 ± 1.1-fold over basal phosphorylation in 12 experiments) which was further enhanced by TPA treatment, whereas PKCε had little effect. TPA had no effect in the absence of PKC overexpression, most likely due to the low levels of endogenous PKCθ in C2C12 cells (24, 29) .
Three consensus sites for Akt phosphorylation (Ser332, Thr348 and Ser350) are indicated by
Scansite analysis even at high stringency, although in comparison to the preferred Arg-X-Arg-X-X-Ser/Thr/-Φ motif (where X is any amino acid and Φ is Leu or Phe) (30), Ser350 lacks the hydrophobic residue at +1, and none of the potential sites has the optimal residues Gly at +2 or Arg at -7 (31). Because we were interested in PKC substrates in relation to insulin signalling, and
Akt is activated by insulin in C2C12 cells, we also investigated whether Ndrg2 could be (Fig. 4) . The minor species were not always observed and may be due to incomplete digestion of Ndrg2. Likewise, pp48 purified from skeletal muscle and phosphorylated in vitro by incubation with PKCθ gave a similar map, strongly supporting the identification of the protein as Ndrg2, and indicating that phosphorylation by PKCθ in vitro occurred on the same tryptic peptide(s) to that in intact cells.
Insulin-stimulated phosphorylation of Ndrg2 mediated by endogenous Akt
We used the phospho-(Ser/Thr) Akt substrate antibody in further experiments to examine the phosphorylation of Ndrg2 by endogenous Akt in differentiated C2C12 myotubes. Insulin, which activates PI3-kinase and hence Akt in C2C12 cells, stimulated the phosphorylation of Ndrg2, which was inhibited by pretreatment with the PI3-kinase inhibitor wortmannin, supporting a role for Akt (Fig. 5A , top panel). While Akt is also involved in the insulin-stimulation of mTOR and p70 S6K , these kinases do not appear to participate in the phosphorylation of Ndrg2, because rapamycin, an inhibitor of mTOR and hence p70 S6K activation, did not affect Ndrg2 phosphorylation (Fig. 5A, top panel) . Similarly, inhibition of ERK1/2 activation with PD98059, or cPKCs with bisindoylmaleimide I, did not reduce Ndrg2 phosphorylation (Fig. 5A, top panel) .
The specificity of the inhibitors used was examined by immunoblotting of the corresponding cell lysates with antibodies against phosphorylated forms of kinases and known substrates (Fig. 5A , lower panels). Thus, rapamycin inhibited the insulin-stimulated phosphorylation of both p70 S6K and 4E-BP1 (substrates of mTOR), but not that of Akt. Importantly, these results demonstrate that Ndrg2 is a novel component of the insulin signalling cascade in muscle cells, and are consistent with direct phosphorylation by Akt.
We have previously shown that Akt stimulation by insulin is inhibited in C2C12 cells by pretreatment with the FFA palmitate, while upstream elements of insulin signalling such as IRS-Ndrg2 in this system. The fatty acid indeed inhibited the insulin-stimulated phosphorylation of Ndrg2 and of Akt (Fig. 5B ). This provides further support for the phosphorylation of Ndrg2 by endogenous Akt, and also demonstrates that the phosphorylation is reduced in insulin resistant muscle cells.
Determination of Ndrg2 phosphorylation sites
Because three putative Akt consensus phosphorylation sites were identified in Ndrg2, we wished to determine which of these were detected by the phospho-(Ser/Thr) Akt substrate antibody.
Ser332 had been identified as a phosphorylation site for PKCθ in partly-purified Ndrg2 in vitro by µLC/ESI-MS/MS analysis (Fig. 2B) , and phosphorylation at this site in intact C2C12 cells overexpressing Ndrg2 was confirmed by this method (not shown). For unknown reasons, however, the theoretical C-terminal tryptic peptide containing Thr348 and Ser350 (indicated in Fig. 2C ) could not be detected by µLC/ESI-MS/MS, preventing further analysis by this method.
Instead, we mutated the three putative Akt phosphorylation sites individually and in combination to Ala, to give four Ndrg2 mutants: Ser332Ala, Thr348Ala, Ser350Ala and Ser332Ala/Thr348Ala/Ser350Ala. These were overexpressed in C2C12 myotubes which were subsequently stimulated with insulin, and phosphorylation again examined with the phosphospecific Akt consensus site antibody. This experiment indicated that Thr348 is the major phosphorylation site detected by the antibody, while mutation of either Ser332 or Ser350 had little effect (Fig. 6A) . The Ser332Ala and Thr348Ala Ndrg2 mutants were also used to examine the phosphorylation of the protein by phosphorimaging of immunoprecipitates of Ndrg2 from [ 32 P]orthophosphate-labelled cells. Ndrg2 in C2C12 cells co-transfected with PKCθ was poorly phosphorylated when Ser332 was mutated to Ala, whereas in cells overexpressing constitutively active Akt, only mutation of Thr348 reduced Ndrg2 phosphorylation (Fig.6B) . Taken together, the results presented in Fig. 6 suggest that insulin stimulates phosphorylation of Ndrg2 primarily at Thr348, which is mediated by Akt, whereas PKCθ phosphorylates the protein principally at Ser332.
Investigation of insulin effects on Ndrg2 protein binding and cellular localisation
Little is known about the direct function of Ndrg proteins. 7A ). In addition, we investigated the effect of insulin on the cellular location of wild type Ndrg2.
Indirect immunofluorescence revealed that the protein is uniformly present in the cytosol of C2C12 cells, and while insulin stimulation caused membrane ruffling, as seen by actin staining of the cells, the hormone had no obvious effect on the cytosolic distribution of Ndrg2 (Fig. 7B ).
This was supported biochemically by fractionation of the cells by differential centrifugation (not shown).
Crosstalk between PKCθ-and Akt-mediated phosphorylation of Ndrg2
Finally, because PKCθ and Akt appear to phosphorylate Ndrg2 at distinct but closely located sites, we examined the effect of nPKCs on basal and insulin-stimulated Ndrg2 phosphorylation in C2C12 cells, detected using the phospho-(Ser/Thr) Akt substrate antibody. In control cells cooverexpressing GFP, the PKC activator TPA reduced insulin-stimulated phosphorylation of Ndrg2 (Fig. 8, first panel, lanes 1-4) . This effect is probably mediated at least in part by the inhibition of insulin-stimulated Akt activation through activation of endogenous PKC, as indicated by the phospho-Ser473 Akt immunoblot (third panel). Importantly, co-overexpression of PKCθ (Fig. 8, lanes 5-8) 
DISCUSSION
We have identified Ndrg2 as a new component of the insulin signalling cascade in skeletal muscle, most likely directly phosphorylated by Akt. The protein is also a specific substrate for PKCθ, and we present evidence that it is a site of crosstalk between the two signalling pathways, and hence of relevance to the development of PKC-mediated insulin resistance in this tissue.
The initial experiments described here indicate that recombinant PKCθ, but not PKCε, is able to phosphorylate a 48 kDa protein in crude and partly-purified skeletal muscle fractions in vitro ( Fig. 1) , which was identified as Ndrg2 (Fig. 2) . This approach to identifying new PKC substrates has a relatively low sensitivity compared to protein expression library and yeast twohybrid interaction screens, and may detect only highly expressed substrates (27) . In addition, it has been argued that PKC substrate specificity in vivo is regulated largely by association with binding partners and hence cellular localisation (2) . Despite these limitations, we have been able to identify a substrate from crude extracts showing isoform selectivity, indicating that the interaction between PKCθ and Ndrg2 has a degree of specificity. It is interesting to note that both of these proteins are in fact highly expressed in skeletal muscle (11,14,32), suggesting that phosphorylation of Ndrg2 by PKCθ in this tissue has physiological importance.
Our subsequent experiments concerning phosphorylation of overexpressed Ndrg2 in 32 P-labelled muscle cells indicated that even in untreated cells, the protein exists in a partly phosphorylated form (Fig. 3B, top panel) , which is not surprising given the large number of potential phosphorylation sites for basophilic kinases near the C-terminus. Phosphorylation was augmented in phorbol ester-stimulated cells co-transfected with PKCθ but not PKCε (Fig. 3A) , in agreement with the in vitro data and suggesting that Ndrg2 is indeed a specific substrate for PKCθ in intact cells. Furthermore, we demonstrated that phosphorylation of the protein could also be increased by overexpression of Akt (Fig. 3B) , as expected from the presence of 3 potential C-terminal Akt phosphorylation sites. The phospho-(Ser/Thr) Akt substrate antibody was therefore employed in further experiments, because this should specifically detect changes in phosphorylation at these sites. This antibody has been used similarly in the identification and characterisation of a number of novel Akt substrates including a Rab-GAP (33) and ATP-citrate lyase (34) .
From our data obtained using pharmacological kinase inhibitors (Fig. 5A) , it is likely that Akt itself phosphorylates Ndrg2 at the sites detected by the antibody, rather than through the activation of additional kinases, such as p70 S6K which has a similar phosphorylation consensus sequence (30). We have not, however, excluded the possibility that SGK, activated in a similar fashion to Akt and exhibiting a similar consensus sequence (35), may also phosphorylate Ndrg2.
This may have physiological relevance in kidney cells, in which both SGK and Ndrg2 are induced rapidly by aldosterone treatment (14, 36) . Although also wortmannin-sensitive, aPKCζ or ι/λ are unlikely to account for the observed insulin-stimulated phosphorylation of Ndrg2 since the aPKC consensus sequence does not fit an Arg-X-Arg-X-X-Ser/Thr motif (37) . In addition, recombinant aPKCζ was unable to phosphorylate pp48 in vitro (not shown).
Use of Ndrg2 mutants indicated that Thr348 is the major phosphorylation site recognised by the phospho-(Ser/Thr) Akt substrate antibody (Fig. 6A) . This is probably the major site of phosphorylation of Ndrg2 by Akt, because mutation of Thr348 to Ala also markedly reduced the Akt-dependent [ 32 P]orthophosphate-labelling of the protein in C2C12 cells (Fig.6B) . In contrast, mutation of Ser332 to Ala demonstrated that this residue was the major site phosphorylated by PKCθ (Fig. 6A ), in agreement with MS data obtained from Ndrg2 phosphorylated in vitro by recombinant PKCθ (Fig. 2B ) or in intact cells overexpressing the kinase (not shown). Although Ser332 resides in an Arg-X-Arg-X-X-Ser motif, its phosphorylation by PKCθ does not appear to be recognised by the phospho-(Ser/Thr) Akt substrate antibody, because PKCθ overexpression in fact decreased Ndrg2 phosphorylation detected by the antibody (Fig. 8) . The two phosphorylation sites identified are predicted to reside in separate tryptic peptides (Fig. 2C) . This is inconsistent with the results of 2-dimensional phosphopeptide mapping, which indicated the presence of only one major phosphopeptide (Fig. 4) . The reason for this discrepancy is unclear, but it is most likely explained by high lability of the tryptic peptide containing Thr348 upon digestion, which is supported by the inability to detect this peptide by µLC/ESI-MS/MS. Thus in cells overexpressing Akt, the major phosphopeptide observed (Fig. 4) probably corresponds to the peptide containing Ser332, phosphorylated by endogenous kinases, while the expected phosphopeptide containing Thr348 is not detected.
The study of Ndrg protein phosphorylation has been limited to Ndrg1 in intact endothelial cells or lysates (15) . Ndrg1 is also Ser-enriched in its C-terminal region, and may be phosphorylated at up to 8 sites according to . The purified protein could be phosphorylated in vitro by PKA, while incubation of whole cells either with forskolin or 8-bromo-cAMP, or under conditions causing oxidative stress, also increased its phosphorylation. Similar to the data presented here for Ndrg2, altered phosphorylation of Ndrg1 did not alter its predominantly cytosolic localisation, and since the biological role of the protein is unclear, it was not possible to determine an effect of phosphorylation on Ndrg1 function. Computational analysis of Ndrg protein structure has suggested that these proteins comprise a novel class in the α/β hydrolase superfamily, which consists of proteins exhibiting the α/β hydrolase fold, mostly enzymes which catalyse a diverse range of reactions (38) . Despite the strong likelihood that Ndrg proteins possess the α/β hydrolase fold, they do not, however, have the expected catalytic motif and do not appear to be hydrolases (38) .
Akt is activated by insulin in its target tissues, including skeletal muscle, and mediates both metabolic and mitogenic effects of the hormone (39, 40) . Because Ndrg2 has been linked to inhibition of proliferation (11), it is possible that insulin-stimulated Akt-dependent phosphorylation modulates effects of the protein on cell growth. Indeed, insulin causes proliferation in C2C12 myoblasts (41), but also promotes myogenesis in these cells in an Aktdependent manner (42). In preliminary experiments, however, we were unable to demonstrate any major effects of Ndrg2 overexpression on myoblast proliferation or differentiation (not shown).
While we were unable to gain insights into Ndrg2 function, we did find evidence that Ndrg2 phosphorylation is diminished under conditions which promote insulin resistance. Firstly, pretreatment of C2C12 myotubes with the saturated FFA palmitate reduced the effect of insulin on phosphorylation of the protein as detected by the phospho-specific antibody (Fig. 5B ). This inhibition is most likely due to the inhibition of Akt through the de novo synthesis of the inhibitory sphingolipid ceramide from palmitate (21, 23) . Secondly, and in contrast to the effects of palmitate, overexpression of PKCθ abolished the insulin-stimulated increase in Ndrg2 phosphorylation while the activation of Akt was unaffected (Fig. 8) . This is consistent with direct phosphorylation of Ndrg2 by PKCθ at Ser332 and inhibition of subsequent phosphorylation by Akt at Thr348. Although PKCε overexpression also reduced Ndrg2 phosphorylation, this is unlikely to involve such sequential phosphorylation, since PKCε phosphorylates Ndrg2 relatively weakly both in vitro (Fig. 1 ) and in intact cells (Fig. 3A) . Since PKCε had a greater effect on basal Ndrg2 phosphorylation at Thr348 (Fig. 8) , it is possible that the inhibitory action of this PKC is not specific to insulin signalling.
Interestingly, both PKCθ and PKCε undergo chronic activation in insulin resistant skeletal muscle from rats fed a safflower oil diet, rich in the unsaturated FFA linoleate (3), and are also activated in C2C12 cells by pretreatment with unsaturated FFAs which promote insulin resistance (24) . Thus it appears that inhibition of insulin action in skeletal muscle cells by either saturated or unsaturated FFAs, acting through distinct mechanisms, will be associated with diminished Ndrg2 phosphorylation by Akt. While activation of PKC, especially PKCθ, has been correlated with insulin resistance in many studies (43), the specific pathways involved are unclear. We suggest that alteration in Ndrg2 phosphorylation plays a role, and could have effects on muscle growth or metabolism (Fig. 9 ).
In summary, we have identified Ndrg2 as a novel substrate for both PKCθ and Akt, and have presented evidence that Ser332 and Thr348 are the respective phosphorylation sites for these kinases. The protein is probably directly phosphorylated by endogenous Akt upon stimulation of muscle cells with insulin, and while the effect of these phosphorylations on the function of the protein remains to be determined, we have demonstrated that the Akt-mediated phosphorylation of Ndrg2 at Thr348 is inhibited by PKCθ, and propose that this crosstalk might represent one mechanism by which lipid-activated PKCs interfere with insulin action. 
